Denmark's Novo Nordisk , the world's biggest maker of insulin, said on Monday it would double the size of its research and development centre in Beijing to 200 employees by 2015.
"The expansion will mainly be dedicated to a new diabetes research unit," Novo Nordisk said in a statement. The company did not give any financial details
BASF sells a majority stake in its coatings business to the investor Carlyle.
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
Compelling solutions through strategic partnerships
Ineos CEO Ineos calls on European politicians to save the chemical industry.
The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.
